Home
>
National Drug Code (NDC)
>
BRILINTA
BRILINTA - 0186-0777-18 - (Ticagrelor)
Drug Information of BRILINTA
| Product NDC: | 0186-0777 |
| Proprietary Name: | BRILINTA |
| Non Proprietary Name: | Ticagrelor |
| Active Ingredient(s): | 90 mg/1 & nbsp; Ticagrelor |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of BRILINTA
| Product NDC: | 0186-0777 |
| Labeler Name: | AstraZeneca LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022433 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110805 |
Package Information of BRILINTA
| Package NDC: | 0186-0777-18 |
| Package Description: | 180 TABLET in 1 BOTTLE (0186-0777-18) |
NDC Information of BRILINTA
| NDC Code | 0186-0777-18 |
| Proprietary Name | BRILINTA |
| Package Description | 180 TABLET in 1 BOTTLE (0186-0777-18) |
| Product NDC | 0186-0777 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ticagrelor |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110805 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca LP |
| Substance Name | TICAGRELOR |
| Strength Number | 90 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
